Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study
Journal of the European Academy of Dermatology and Venereology · 2026
DOI: 10.1111/jdv.20638 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2026. Verfasst von Lía Bejarano und 23 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Lymphoma, T-Cell, Cutaneous, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Advanced cutaneous T‐cell lymphomas (CTCL) are rare, generally refractory to therapeutic options, and have a poor prognosis. Haematopoietic stem cell transplantation (HSCT), mainly allogeneic HSCT (allo‐HSCT), is considered a potentially curative option in CTCL refractory to other therapies. However, around half of patients relapse, and allo‐HSCT is associated with significant adverse events. The available evidence on the usefulness of HSCT in CTCL generally comes from isolated cases and case series with a limited number of patients.
Objectives
Our aim was to evaluate the outcome of patients undergoing HSCT for advanced primary CTCL in Spain in a real‐world environment and to compare their survival with that of similar patients who did not receive HSCT.
Methods
We performed a retrospective observational study nested within the Primary Cutaneous Lymphoma Registry (RELCP) of the Spanish Academy of Dermatology and Venereology, collecting data on all patients receiving HSCT. Then, we performed propensity score matching (PSM) to pair HSCT patients with non‐HSCT patients, adjusting for diagnosis, highest disease stage and age at diagnosis. We then performed survival analysis by means of Cox regression.
Results
Of 2848 patients included in the RELCP, 51 patients underwent HSCT. Thirty‐six patients (70.6%) achieved a complete response and seven patients (13.7%) partial response. Relapse was developed by 56.9% of patients, and 39.2% died (19.6% due to disease progression and 15.7% due to HSCT complications, mainly graft‐versus‐host disease (GVHD) and sepsis). Overall survival (OS) after HSCT at 5 years was 58.9%. No differences in OS were found between HSCT and non‐HSCT groups.
Conclusions
We did not observe a survival benefit among HSCT patients compared to non‐HSCT patients within the RELCP cohort. This could be due to patients having received a mean of 6.3 lines of treatment before HSCT. Larger studies might help identify subgroups of patients who might benefit from HSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Dermatology Department, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
- Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
- Research Unit, Spanish Academy of Dermatology and Venereology, Madrid, Spain.
- Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Dermatology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
- Dermatology Department, Hospital Universitari de Bellvitge, Barcelona, Spain.
ORCID-Profile: Cristina Muniesa, Juan Torre-Castro, Yeray Peñate, Ricardo Fernández-de-Misa, Helena Iznardo, Carlos Moreno-Vílchez, Octavio Servitje, Javier Cañueto
Zitieren
APA
Bejarano, L., Grau-Pérez, M., Paíno-Román, M., Muret, M. P. G., Morillo, M., Muniesa, C., Torre-Castro, J., Estrach, M. T., Díez, E. A., Belloso, R. M. L., Peñate, Y., Martínez-Mera, C., Botella-Estrada, R., Eceiza, M. J. M., Ortiz Romero, P. L., Blanes, M., Fernández-de-Misa, R., Prieto-Torres, L., Amer, M. E. P., …, & Cañueto, J. (2026). Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.20638
Vancouver
Bejarano L, Grau-Pérez M, Paíno-Román M, Muret MPG, Morillo M, Muniesa C, et al. Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study. Journal of the European Academy of Dermatology and Venereology. 2026. doi:10.1111/jdv.20638
BibTeX
@article{Bejarano2026,
author = {Bejarano, Lía and Grau-Pérez, Mercè and Paíno-Román, Marina and Muret, María Pilar García and Morillo, Mercedes and Muniesa, Cristina and Torre-Castro, Juan and Estrach, M Teresa and Díez, Elena Amutio and Belloso, Rosa Mª Lzu and Peñate, Yeray and Martínez-Mera, Constanza and Botella-Estrada, Rafael and Eceiza, Miren Josune Michelena and Ortiz Romero, Pablo L and Blanes, Mar and Fernández-de-Misa, Ricardo and Prieto-Torres, Lucía and Amer, María Elisabet Parera and Iznardo, Helena and Moreno-Vílchez, Carlos and Servitje, Octavio and García-Doval, Ignacio and Cañueto, Javier},
title = {Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
doi = {10.1111/jdv.20638}
}
EUVIMED